机译:EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study
Memorial Sloan Kettering Cancer Center;
Barts Cancer Institute Queen Mary University of London and St Bartholomew's Hospital;
Institut BergonieRoyal Marsden Hospital The Institute of Cancer ResearchWythenshawe Hospital Manchester University NHS Foundation TrustInstitut Gustave RoussyHospital of the University (CHU) de LilleCity of Hope National Medical CenterUCL Cancer Institute and University College London HospitalsDepartment of Thoracic Surgery University of CaliforniaMayo ClinicEpizymeLeicester Cancer Research Centre University of Leicester and University Hospitals of Leicester NHS;